Gerd Sutter

City:

Munchen

Country:

Germany

Published Applications:

Last publication date:

2023-11-02

Top Assignees for applications by Gerd Sutter

The entities that hold a legal rights for patent applications filed by inventor Sutter Gerd:

Rojas Exposito Juan José 1 Munich, Germany
Sutter Gerd 1 Munich, Germany
Marion Dorothea Kristin-Sutter 1 Munich, Germany
Juan José Rojas Exposito 1 Munich, Germany
GSF-Forschungszentrum fur Umwelt und Gesundheit, GmbH 1 Munich, Germany
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) 1 Neuherberg, Germany
GFS Forschungszentrum fur Umwelt und Gesundheit GmbH 1 Neuherberg, Germany
PAUL-EHRLICH-INSTITUT BUNDESAMT FUR SERA UND IMPFSTOFFE 1 Langen, Germany

Recent patent applications by Sutter Gerd

Gerd Sutter from Munchen, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-11-02

US20230346863A1

Human necessities

Immuno-modulated replication-efficient Vaccinia virus strain

#2 | 2020-12-03

US20200376051A1

Human necessities

Immuno-modulated replication-efficient vaccinia virus strain

#3 | 2013-04-11

US20130089569A1

Human necessities

RECOMBINANT MVA CAPABLE OF EXPRESSING STRUCTURAL HCV ANTIGENS

#4 | 2011-12-01

US20110293656A1

Human necessities

RECOMBINANT MVA CAPABLE OF EXPRESSING STRUCTURAL HCV ANTIGENS

#5 | 2011-01-27

US20110020391A1

Human necessities

RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA)-BASED VACCINE FOR THE AVIAN FLU

#6 | 2009-09-24

US20090238843A1

Human necessities

RECOMBINANT MVA CAPABLE OF EXPRESSING STRUCTURAL HCV ANTIGENS

#7 | 2006-12-19

US10668521

Vector for integration of heterologous sequences into poxviral genomes

#8 | 2006-06-15

US20060127413A1

Chemistry; metallurgy

Recombinant mva strains as potential vaccines against p. falciparum malaria

#9 | 2005-02-03

US20050028226A1

Chemistry; metallurgy

Vaccinia virus MVA-E3L-knockout-mutants and use thereof

#10 | 2005-01-27

US20050019347A1

Human necessities

Recombinant mva capable of expressing structural hcv antigens

InventorID:

186268 ⎘